Orthofix Medical (OFIX) Gross Margin (2010 - 2026)
Orthofix Medical (OFIX) posted Gross Margin of 70.94% for Q1 2026, up 15.92% on a QoQ basis from 61.2% in Q4 2025, and up 814.0% year-over-year from 7.76% in Q1 2025.
Orthofix Medical (OFIX) Gross Margin (2010 - 2026) Analysis & Trends
Orthofix Medical's Gross Margin history runs 17 years deep, the most recent figure standing at 70.94% for Q1 2026.
- Quarterly Gross Margin rose 814.0% year-over-year to 70.94% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 67.83% (up 272.0% YoY) and the FY2025 annual result came in at 68.83%, up 55.0% from the prior year.
- Gross Margin was 70.94% for Q1 2026 at Orthofix Medical, up from 61.2% in the prior quarter.
- Across five years, Gross Margin topped out at 73.39% in Q1 2022 and bottomed at 58.55% in Q4 2024.
- A 5-year average of 68.31% and a median of 68.69% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2022 — Gross Margin sank 5794 bps — and 2024, when it surged 875 bps.
- Orthofix Medical's Gross Margin stood at 72.96% in 2022, then dropped by 7 bps to 68.17% in 2023, then decreased by 14 bps to 58.55% in 2024, then increased by 5 bps to 61.2% in 2025, then rose by 16 bps to 70.94% in 2026.
- Business Quant data shows OFIX's Gross Margin at 70.94% in Q1 2026, 61.2% in Q4 2025, and 72.23% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Orthofix Medical | 443.33 Mn | 322.46 Mn | 139.55 Mn | 70.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.94% |
| Dec 31, 2025 | 61.20% |
| Sep 30, 2025 | 72.23% |
| Jun 30, 2025 | 68.69% |
| Mar 31, 2025 | 62.80% |
| Dec 31, 2024 | 58.55% |
| Sep 30, 2024 | 68.69% |
| Jun 30, 2024 | 72.67% |
| Mar 31, 2024 | 67.46% |
| Dec 31, 2023 | 68.17% |
| Sep 30, 2023 | 65.09% |
| Jun 30, 2023 | 63.93% |
| Mar 31, 2023 | 68.00% |
| Dec 31, 2022 | 72.96% |
| Sep 30, 2022 | 73.18% |
| Jun 30, 2022 | 73.24% |
| Mar 31, 2022 | 73.39% |
| Dec 31, 2021 | 130.90% |
| Sep 30, 2021 | 74.82% |
| Jun 30, 2021 | 77.40% |